Healthcare Services vs National HealthCare
HCSG and NHC side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HCSG and NHC compare
National HealthCare is the larger company, worth 1.9 times as much as Healthcare Services ($3.2B against $1.7B).
On earnings, Healthcare Services is cheaper: it trades at 16.7× trailing earnings, against 23.3× for National HealthCare.
National HealthCare grew revenue faster over the last twelve months (6.9% versus 4.0% for Healthcare Services).
National HealthCare keeps more of each dollar of sales as profit, with a net margin of 9.0% compared with 5.6% at Healthcare Services.
National HealthCare pays a dividend yielding 1.3%; Healthcare Services does not pay one.
National HealthCare scores higher on the StockData Score (20 against 18 for Healthcare Services), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HCSG | NHC |
|---|---|---|
| Size and price | ||
| Market cap | $1.7B | $3.2B |
| Share price | $24.86 | $207.19 |
| Change, 1 year | 43.4% | 63.6% |
| Change, 5 years | 39.9% | 209% |
| Beta (5Y) | 0.27 | −0.26 |
| Employees | 36K | 15K |
| StockData Score | ||
| Total score | 18 | 20 (better) |
| Valuation score | 5 (better) | 2 |
| Growth score | 4 (better) | 3 |
| Performance score | 3 | 5 (better) |
| Health score | 6 | 6 |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | 16.7× (better) | 23.3× |
| P/S | 0.9× (better) | 2.1× |
| P/B | 3.2× | 2.9× (better) |
| EV/EBITDA | 10.5× (better) | 16.9× |
| P/FCF | 15.7× (better) | 22.1× |
| PEG | 0.80 | 0.31 (better) |
| FCF yield | 6.4% (better) | 4.5% |
| Fair value | $30.37 | $171.90 |
| Margin of safety | 18.1% (better) | −20.5% |
| Growth | ||
| Revenue growth (TTM) | 4.0% | 6.9% (better) |
| Revenue growth, 5Y average | 0.86% | 8.1% (better) |
| Net income growth (TTM) | 164% (better) | 33.8% |
| EPS growth (TTM) | 176% (better) | 32.5% |
| EPS growth, 5Y average | −9.3% | 23.0% (better) |
| Profitability | ||
| Gross margin | 16.1% | – |
| Operating margin | – | 9.3% |
| Net margin | 5.6% | 9.0% (better) |
| FCF margin | 5.7% | 9.4% (better) |
| Return on equity | 20.4% (better) | 13.1% |
| Return on invested capital | – | 10.6% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Net debt / EBITDA | – | −0.21 |
| Interest coverage | – | 56.6× |
| Current ratio | 2.82 (better) | 1.86 |
| Altman Z-score | 6.48 | 7.06 (better) |
| Piotroski F-score | 8 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | – | 1.3% |
| Payout ratio | – | 28.4% |
| Years of dividend growth | – | 12 |
| Dividend growth, 5Y average | – | 4.0% |
| Buyback yield | 4.5% (better) | 0.14% |
| Shareholder yield | 4.5% (better) | 1.4% |
| Ownership | ||
| Held by institutions | 108% | 65.3% |
| Held by insiders | 1.3% | 9.3% |
| Insider net buying, 12 months | −$3.8M (better) | −$9.1M |
| Short interest, % of float | 3.7% | 5.4% |
Go deeper
- HCSG stock overview
- HCSG income statement
- HCSG valuation and score
- NHC stock overview
- NHC income statement
- NHC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.